Background: Reports on medium and long-term sequelae of SARS-CoV-2 infections largely lack quantification of incidence and relative risk. We describe the rationale and methods of the Innovative Support for Patients with SARS-CoV-2 Registry (INSPIRE) that combines patient-reported outcomes with data from digital health records to understand predictors and impacts of SARS-CoV-2 infection.
Methods: INSPIRE is a prospective, multicenter, longitudinal study of individuals with symptoms of SARS-CoV-2 infection in eight regions across the US. Adults are eligible for enrollment if they are fluent in English or Spanish, reported symptoms suggestive of acute SARS-CoV-2 infection, and if they are within 42 days of having a SARS-CoV-2 viral test (i.e., nucleic acid amplification test or antigen test), regardless of test results. Recruitment occurs in-person, by phone or email, and through online advertisement. A secure online platform is used to facilitate the collation of consent-related materials, digital health records, and responses to self-administered surveys. Participants are followed for up to 18 months, with patient-reported outcomes collected every three months via survey and linked to concurrent digital health data; follow-up includes no in-person involvement. Our planned enrollment is 4,800 participants, including 2,400 SARS-CoV-2 positive and 2,400 SARS-CoV-2 negative participants (as a concurrent comparison group). These data will allow assessment of longitudinal outcomes from SARS-CoV-2 infection and comparison of the relative risk of outcomes in individuals with and without infection. Patient-reported outcomes include self-reported health function and status, as well as clinical outcomes including health system encounters and new diagnoses.
Results: Participating sites obtained institutional review board approval. Enrollment and follow-up are ongoing.
Conclusions: This study will characterize medium and long-term sequelae of SARS-CoV-2 infection among a diverse population, predictors of sequelae, and their relative risk compared to persons with similar symptomatology but without SARS-CoV-2 infection. These data may inform clinical interventions for individuals with sequelae of SARS-CoV-2 infection.
Recommended CitationO'Laughlin, Kelli N; Thompson, Matthew; Hota, Bala; Gottlieb, Michael; Plumb, Ian D; Chang, Anna Marie; Wisk, Lauren E; Hall, Aron J; Wang, Ralph C; Spatz, Erica S; Stephens, Kari A; Huebinger, Ryan M; McDonald, Samuel A; Venkatesh, Arjun; Gentile, Nikki; Slovis, B. H.; Hill, Mandy; Saydah, Sharon; Idris, Ahamed H; Rodriguez, Robert; Krumholz, Harlan M; Elmore, Joann G; Weinstein, Robert A; and Nichol, Graham, "Study protocol for the Innovative Support for Patients with SARS-COV-2 Infections Registry (INSPIRE): A longitudinal study of the medium and long-term sequelae of SARS-CoV-2 infection" (2022). Department of Emergency Medicine Faculty Papers. Paper 173.
Creative Commons License
This work is licensed under a Creative Commons Public Domain Dedication 1.0 License.